Synthesis modules / TRACERlab FX2 C
TRACERlab FX2 C
- Manufacturer
- GE HealthCare
- Cassette-based
- No
- Syntheses indexed
- 5
Yields from different papers are not directly comparable: starting activity, decay correction and scale differ between groups. Read the count of independent reports rather than the highest number. Why
From the literature
What has been made on it
| Agent | Cassette | Purification | Yield % | Time, min | Regulatory | Source |
|---|---|---|---|---|---|---|
| [11C]acetate | custom manifold | SPE | 35.8 ± 9.9% | 10 | — | 41452397 2025 |
| [11C]acetoacetate | custom manifold | HPLC | 4.67 ± 1.36% | 15 | — | 41452397 2025 |
| [11C]KIn83 | — | HPLC+SPE | 622 MBq average yield | — | GMP | 40142141 2025 |
| [11C]6-bromopurine | fixed tubing | HPLC+SPE | 20.5 ± 5.2% | 43 min | CTA | 38683266 2024 |
| [11C]Me-NB1 | — | HPLC+SPE | — | — | — | 36018389 2022 |
From the manufacturer
No manufacturer-submitted profile yet. Everything above comes from published papers, not from TRACERlab FX2 C itself.
Choosing a synthesis module?Tell us what you plan to produce and we will help you compare TRACERlab FX2 C against the alternatives.
Get in touch